5-177402596-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM1BP4_Moderate
The NM_000505.4(F12):c.1634G>A(p.Gly545Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,613,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_000505.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
F12 | NM_000505.4 | c.1634G>A | p.Gly545Asp | missense_variant | 13/14 | ENST00000253496.4 | |
F12 | XM_011534462.3 | c.1298G>A | p.Gly433Asp | missense_variant | 10/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
F12 | ENST00000253496.4 | c.1634G>A | p.Gly545Asp | missense_variant | 13/14 | 1 | NM_000505.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 248458Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134922
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1460668Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 726620
GnomAD4 genome AF: 0.000151 AC: 23AN: 152344Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74498
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.1634G>A (p.G545D) alteration is located in exon 13 (coding exon 13) of the F12 gene. This alteration results from a G to A substitution at nucleotide position 1634, causing the glycine (G) at amino acid position 545 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at